Announcement as per Reg 30-Letter of Offer
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aspira Pathlab & Diagnostics has informed BSE that it has received the Letter of Offer for an Open Offer made by five acquirers — Arvind Karsandas Bhanushali, Deepali Arvind Bhanushali, Jay Arvind Bhanushali, Nikunj Velji Mange, and Raj Arvind Bhanushali — along with PAC Shraddha Nikunj Mange. The offer is for up to 26,76,180 equity shares (26% of voting capital) at ₹55 per share, totalling about ₹14.72 crore. It is a triggered open offer under SEBI Takeover Regulations, linked to a change in control of the company. After the offer, the acquirers together with the PAC will hold 49.82% of the voting share capital. The tendering period runs from November 24, 2025 to December 5, 2025, with payment expected within 10 working days of closure.
Public shareholders can choose to tender their shares at ₹55 during the tendering window. The offer signals a change in control at Aspira Pathlab, with the acquirer group crossing the 49.82% mark, which may influence the stock price and prompt shareholders to evaluate whether to hold or exit at the offer price.